Profile_bird

Hey there! JClionsden is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving JClionsden's tweets.

Already using Twitter
from your phone? Click here.

JClionsden

  1. Am in Germany where general election is this Sunday. Wonder if Sunday voting increases turnout?
  2. 'Biggst advnces in onco therpy not fm new drugs but fm patient selection'.. Quote fm debate. #ECCO/ESMO
  3. Just finished moderating #ECCO/ESMO media debate re biomarkers. Seemed to go well.
  4. RT FiercePharma: RT @WSJHealthBlog: Glaxo to Curb Funding to Commercial Medical-Education Programs http://bit.ly/cF0om
  5. Am at #ECCO/ESMO in Berlin. Hosting media debate 2moro. Anyone else here?
  6. Is the ECCO/ESMO hashtag just #ECCO or something more complicated?
  7. 0715 Monday am in security q @ Heathrow T5. On way to #ECCO in Berlin. Even Fast Trk q v slow.
  8. Man U 4 Man C 3. Best derby in 40 yrs. As BBC Phil McNulty sd the game had everything except defending.
  9. @pharmaguy I saw this on Blue Peter years ago...gd stunt and not poss.
  10. @swoodruff glad to see I'm not the only pedant on here! Ru British?
  11. Sitting by Lake Geneva in Lausanne with coffee and apple tart waiting for Lionsden colleagues. Perfect.
  12. @jonmrich I say I'm on Twitter. To which most pple say 'why?'. But they just don't get it!
  13. @jonmrich don't get bogged down in nomenclature. We in the know know what it is...unlike so many other non-tweeps.
  14. @JamesHarper: u know what memberships are like! They want jam today. Last year indstry hardly even talked to govt. Give it time.
  15. @JamesHarper did u c my tweetback?
  16. @LizShanahan yes and don't get same scrutiny but unlike drugs pacmakers need near 100% efficacy.
  17. @Pharmafocus and details eg Innovation Pass need be clarified.
  18. @Pharmafocus so it's a trend in rt dirction but yes OLS needs deliver.
  19. @Pharmafocus altntve view is that 50% of industry skeptical of OLS is big imprvmnt. Last year ws 89%.
  20. Just arrived in Genva. On way to Lausanne for Medtronic. Rare foray into med dvcs 4 me.